AAAAAA

   
Results: 1-25 | 26-50 | 51-54
Results: 26-50/54
The scythridid fauna of the southern Ural Mountains, with description of fourteen new species (Lepidoptera : Scythrididae)
Authors: Nupponen, K Bengtsson, BA Kaitila, JP Nupponen, T Junnilainen, J Olschwang, V
Citation: K. Nupponen et al., The scythridid fauna of the southern Ural Mountains, with description of fourteen new species (Lepidoptera : Scythrididae), ENTOMOL FEN, 11(1), 2000, pp. 5-34
Growth hormone deficiency and replacement in elderly hypopituitary adults
Authors: Monson, JP Abs, R Bengtsson, BA Bennmarker, H Feldt-Rasmussen, U Hernberg-Stahl, E Thoren, M Westberg, B Wilton, P Wuster, C
Citation: Jp. Monson et al., Growth hormone deficiency and replacement in elderly hypopituitary adults, CLIN ENDOCR, 53(3), 2000, pp. 281-289
Can growth hormone therapy cause diabetes?
Authors: Monson, JP Bengtsson, BA Abs, R Feldt-Rasmussen, U Wuster, C
Citation: Jp. Monson et al., Can growth hormone therapy cause diabetes?, LANCET, 355(9216), 2000, pp. 1728-1728
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
Authors: Trainer, PJ Drake, WM Katznelson, L Freda, PU Herman-Bonert, V van der Lely, AJ Dimaraki, EV Stewart, PM Friend, KE Vance, ML Besser, GM Scarlett, JA Thorner, MO Parkinson, C Klibanski, A Powell, JS Barkan, AL Sheppard, MC Maldonado, M Rose, DR Clemmons, DR Johannson, G Bengtsson, BA Stavrou, S Kleinberg, DL Cook, DM Phillips, LS Bidlingmaier, M Strasburger, CJ Hackett, S Zib, K Bennett, WF Davis, RJ
Citation: Pj. Trainer et al., Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant, N ENG J MED, 342(16), 2000, pp. 1171-1177
The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats
Authors: Svensson, J Lall, S Dickson, SL Bengtsson, BA Romer, J Ahnfelt-Ronne, I Ohlsson, C Jansson, JO
Citation: J. Svensson et al., The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats, J ENDOCR, 165(3), 2000, pp. 569-577
Pituitary adenomas in Sweden between 1958 and 1991: Incidence, survival, and mortality
Authors: Nilsson, B Gustavsson-Kadaka, E Bengtsson, BA Jonsson, B
Citation: B. Nilsson et al., Pituitary adenomas in Sweden between 1958 and 1991: Incidence, survival, and mortality, J CLIN END, 85(4), 2000, pp. 1420-1425
Treatment of growth hormone deficiency in adults
Authors: Bengtsson, BA Johannsson, G Shalet, SM Simpson, H Sonken, PH
Citation: Ba. Bengtsson et al., Treatment of growth hormone deficiency in adults, J CLIN END, 85(3), 2000, pp. 933-937
Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society
Authors: Israel, E Attie, KM Bengtsson, BA Blethen, SL Blum, W Cameron, F Carel, JC Carlsson, L Chipman, JJ Christiansen, JS Clayton, P Clemmons, DR Cohen, P Drop, S Fujieda, K Ghigo, E Hintz, RL Ho, K Ilondo, MM Jasper, H Jesussek, B Kappelgaard, AM Laron, Z Lippe, BM Malozowski, S Mullis, PE de Munick-Keizer-Schrama, S Nishi, Y Parks, JS Phelps, C Ranke, M Robinson, I Rosenfeld, RG Rose, S Saenger, P Saggese, G Savage, M Shalet, S Sizonenko, PC Strasburger, C Tachibana, K Tanaka, T Thorner, MO Wikland, KA Zadik, Z
Citation: E. Israel et al., Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society, J CLIN END, 85(11), 2000, pp. 3990-3993
The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men
Authors: Dall, R Longobardi, S Ehrnborg, C Keay, N Rosen, T Jorgensen, JOL Cuneo, RC Boroujerdi, MA Cittadini, A Napoli, R Christiansen, JS Bengtsson, BA Sacca, L Baxter, RC Basset, EE Sonksen, PH
Citation: R. Dall et al., The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men, J CLIN END, 85(11), 2000, pp. 4193-4200
Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males
Authors: Wallace, JD Cuneo, RC Lundberg, PA Rosen, T Jorgensen, JOL Longobardi, S Keay, N Sacca, L Christiansen, JS Bengtsson, BA Sonksen, PH
Citation: Jd. Wallace et al., Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males, J CLIN END, 85(1), 2000, pp. 124-133
The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction
Authors: Tivesten, A Bollano, E Caidahl, K Kujacic, V Sun, XY Hedner, T Hjalmarson, A Bengtsson, BA Isgaard, J
Citation: A. Tivesten et al., The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction, ENDOCRINOL, 141(1), 2000, pp. 60-66
Growth hormone and syndrome x
Authors: Johannsson, G Marin, P Johansson, JO Bengtsson, BA
Citation: G. Johannsson et al., Growth hormone and syndrome x, CONT ENDOC, 19, 2000, pp. 247-260
Clinical and experimental effects of growth hormone secretagogues on various organ systems
Authors: Svensson, J Bengtsson, BA
Citation: J. Svensson et Ba. Bengtsson, Clinical and experimental effects of growth hormone secretagogues on various organ systems, HORMONE RES, 51, 1999, pp. 16-20
Postmenopausal osteoporosis is more related to hormonal aberrations than to lifestyle factors
Authors: Landin-Wilhelmsen, K Wilhelmsen, L Bengtsson, BA
Citation: K. Landin-wilhelmsen et al., Postmenopausal osteoporosis is more related to hormonal aberrations than to lifestyle factors, CLIN ENDOCR, 51(4), 1999, pp. 387-394
GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety
Authors: Abs, R Bengtsson, BA Hernberg-Stahl, E Monson, JP Tauber, JP Wilton, P Wuster, C
Citation: R. Abs et al., GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety, CLIN ENDOCR, 50(6), 1999, pp. 703-713
Discrepancy between serum leptin values and total body fat in response to the oral growth hormone secretagogue MK-677
Authors: Svensson, J Carlsson, B Carlsson, LMS Jansson, JO Bengtsson, BA
Citation: J. Svensson et al., Discrepancy between serum leptin values and total body fat in response to the oral growth hormone secretagogue MK-677, CLIN ENDOCR, 50(4), 1999, pp. 451-456
Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: Anabolic effect and functional improvement
Authors: Johannsson, G Bengtsson, BA Ahlmen, J
Citation: G. Johannsson et al., Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: Anabolic effect and functional improvement, AM J KIDNEY, 33(4), 1999, pp. 709-717
Rethink about growth-hormone therapy for critically ill patients
Authors: Bengtsson, BA
Citation: Ba. Bengtsson, Rethink about growth-hormone therapy for critically ill patients, LANCET, 354(9188), 1999, pp. 1403-1404
Effect of growth-hormone therapy on early atherosclerotic changes in GH-deficient adults
Authors: Bengtsson, BA Johannsson, G
Citation: Ba. Bengtsson et G. Johannsson, Effect of growth-hormone therapy on early atherosclerotic changes in GH-deficient adults, LANCET, 353(9168), 1999, pp. 1898-1899
Possible protective role of growth hormone in hypoxia-ischemia in neonatalrats
Authors: Gustafson, K Hagberg, H Bengtsson, BA Brantsing, C Isgaard, J
Citation: K. Gustafson et al., Possible protective role of growth hormone in hypoxia-ischemia in neonatalrats, PEDIAT RES, 45(3), 1999, pp. 318-323
Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins, but not lipoprotein(a)
Authors: Svensson, J Jansson, JO Ottosson, M Johannsson, G Taskinen, MR Wiklund, O Bengtsson, BA
Citation: J. Svensson et al., Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins, but not lipoprotein(a), J CLIN END, 84(6), 1999, pp. 2028-2033
Growth hormone (GH) therapy in GH-deficient adults influences the responseto a dietary load of cholesterol and saturated fat in terms of cholesterolsynthesis, but not serum low density lipoprotein cholesterol levels
Authors: Leonsson, M Oscarsson, J Bosaeus, I Lundgren, BK Johannsson, G Wiklund, O Bengtsson, BA
Citation: M. Leonsson et al., Growth hormone (GH) therapy in GH-deficient adults influences the responseto a dietary load of cholesterol and saturated fat in terms of cholesterolsynthesis, but not serum low density lipoprotein cholesterol levels, J CLIN END, 84(4), 1999, pp. 1296-1303
Discontinuation of growth hormone (GH) treatment: Metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects
Authors: Johannsson, G Albertsson-Wikland, K Bengtsson, BA
Citation: G. Johannsson et al., Discontinuation of growth hormone (GH) treatment: Metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects, J CLIN END, 84(12), 1999, pp. 4516-4524
The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults
Authors: Bengtsson, BA Abs, R Bennmarker, H Monson, JP Feldt-Rasmussen, U Hernberg-Stahl, E Westberg, B Wilton, P Wuster, C
Citation: Ba. Bengtsson et al., The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults, J CLIN END, 84(11), 1999, pp. 3929-3935
Growth hormone replacement therapy is not associated with any increase in mortality
Authors: Bengtsson, BA Koppeschaar, HPF Abs, R Bennmarker, H Hernberg-Stahl, E Westberg, B Wilton, P Monson, JP Feldt-Rasmussen, U Wuster, C
Citation: Ba. Bengtsson et al., Growth hormone replacement therapy is not associated with any increase in mortality, J CLIN END, 84(11), 1999, pp. 4291-4292
Risultati: 1-25 | 26-50 | 51-54